US Futures mixed - Watch AMAT, TSLA, QGEN

,

The S&P 500 Futures are under pressure after they held up at recent highs yesterday

Stocks (2)

The S&P 500 Futures are under pressure after they held up at recent highs yesterday. The treasury yields rose again - 10-year Treasury yield advanced to 0.716% - after the record 30-year US bond auction saw weak demand, raising fears that debt market may not absorb additional debt easily.

Later today, the U.S. Commerce Department will release July retail sales (+2.1% on month expected) and June business inventories (-1.1% on month expected). The Federal Reserve will report July industrial production (+3.0% on month expected) and capacity utilization (70.3% expected). The University of Michigan will publish its Consumer Sentiment Index for August (72.0 expected). 

European indices are facing a strong down move. The European Commission has reported 2Q GDP at -12.1% (vs -3.6% in 1Q) and June trade balance at 17.1 billion euros surplus (vs 14.5 billion euros surplus expected). France's INSEE has posted final readings of July CPI at +0.8% on year, as expected.

Asian indices closed in the green except the Hong Kong HSI. Earlier today, official data showed that China's industrial production grew 4.8% on year in July (+5.1% expected) while retail sales dropped 1.1% (+0.1% expected).

WTI Crude Oil futures are turning down after the International Energy Agency lowered its 2020 global oil demand forecast to 91.1 million barrels per day, reflecting a fall of 8.1 million barrels per day as compared with 2019.

Gold continues to consolidate, close to its first weekly decline after posting record highs.

Gold fell 7.32 dollars (-0.37%) to 1946.39 dollars.

AUD/USD fell 3pips to 0.7146. The pair consolidates on bad China data after a seven-week winning streak.


U.S. Equity Snapshot


Applied Materials (AMAT), the global leader in materials engineering solutions for the semiconductor industry, reported third quarter adjusted EPS up to 1.06 dollar from 0.74 dollar a year earlier on sales up to 4.39 billion dollars from 3.6 billion dollars a year ago. Those figures beat estimates.


Source: TradingView, GAIN Capital

Tesla (TSLA), the electric-vehicle maker, was upgraded to "equal-weight" from "underweight" at Morgan Stanley.

QIAGEN (QGEN), a biotech company specialized in applications in life sciences and molecular diagnostics, was raised to "buy" from "hold" at Deutsche Bank.

More from Equities

Join our live webinars for the latest analysis and trading ideas. Register now

GAIN Capital UK Limited (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.